Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 11 Issue 2, February 2010

Neurons in in vitro culture are exposed to inflammatory mediators released by β-amyloid-activated microglial cells. Moore and colleagues (p 155) show that a CD36-TLR4-TLR6 heterotrimer mediates β-amyloid recognition and microglial cell activation in the brain. The original confocal image shows CAD mouse neuronal cells cultured together with microglial cells stimulated with Aβ1–42 and stained with antibody to neuronal class III β-tubulin (green). DAPI nuclear staining is blue. Original image by Janine M van Gils and Laurent Boyer. Artwork by Lewis Long.

Editorial

  • Gender stereotypes prevent women from attaining full recognition of their research careers.

    Editorial

    Advertisement

Top of page ⤴

Essay

Top of page ⤴

News & Views

  • The signaling intermediates that activate inflammasomes are elusive. New data now show that reactive oxygen species causes TXNIP to associate with NLRP3 and activate the inflammasome.

    • Beckley K Davis
    • Jenny Pan-Yun Ting
    News & Views
  • The mutator activation-induced cytidine deaminase is essential for immunoglobulin diversification but can be detrimental in other settings. A new comprehensive analysis investigates how its gene expression is regulated.

    • Mieun Lee-Theilen
    • Jayanta Chaudhuri
    News & Views
  • CTLA-4 is a potent coinhibitory molecule that is critical for peripheral T cell tolerance. New data suggest that CTLA-4 exerts its critical immunoregulatory functions by controlling antigen-specific conventional T cells as well as regulatory T cells.

    • Alison M Paterson
    • Arlene H Sharpe
    News & Views
  • Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell–mediated recognition of pancreatic beta cells.

    • Francesco Colucci
    • Corrado M Cilio
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Search

Quick links